Intellia Therapeutics, Inc. · NASDAQ:NTLA
Intellia Therapeutics, Inc. shareholders
As of Jun 30, 2026, 315 institutions reported holding Intellia Therapeutics, Inc. Largest: ARK, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Intellia Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| ARK | 16.9M | +2.37M | Aug 14, 2026 | |
| BlackRock | 15.4M | +3.25M | Aug 7, 2026 | |
| Vanguard | 14.5M | +2.24M | Aug 13, 2026 | |
| State Street | 9.23M | +2.31M | Aug 7, 2026 | |
| D. E. Shaw & Co., Inc. | 6.44M | +715K | Aug 14, 2026 | |
| Two Sigma | 5.25M | +549K | Aug 14, 2026 | |
| Fidelity | 4.77M | +2.71M | Aug 13, 2026 | |
| Ra Capital Management, L.P. | 4.53M | new | Aug 14, 2026 | |
| Regeneron Pharmaceuticals, Inc. | 3.7M | no change | Aug 7, 2026 | |
| Geode Capital | 3.63M | +780K | Aug 12, 2026 |